B.F. Modaraba (PSX:BFMOD)

ShockWave Medical Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	19.37	6.27	-6	-15.11	5.51	2.66
Depreciation & Amortization	0	0	0	0	0	0
Loss (Gain) From Sale of Investments	-0.73	-	-1.08	-2.25	-3.35	0.47
Loss (Gain) on Equity Investments	-	-	7.42	15.38	-	-
Change in Accounts Payable	-0.95	-0.95	-0.55	0.05	-0.85	1.18
Change in Other Net Operating Assets	5.77	1.25	-8.8	-0.47	0.01	15.04
Other Operating Activities	-0.46	12.98	53.13	29.19	-10.16	-9.92
Operating Cash Flow	64.69	25.91	-3.93	26.81	-8.83	9.43
Investment in Securities	14.87	-	-	-	-	-
Net Decrease (Increase) in Loans Originated / Sold - Investing	8.84	-17.13	2.69	-23.39	-14	-
Other Investing Activities	4.49	1.2	0.33	0.12	0.65	2.43
Investing Cash Flow	28.2	-15.93	3.02	-23.26	-13.35	2.43
Common Dividends Paid	-	-	-	-3.61	-	-
Financing Cash Flow	-	-	-	-3.61	-	-
Net Cash Flow	92.9	9.98	-0.91	-0.07	-22.19	11.86
Free Cash Flow	64.69	25.91	-3.93	26.81	-8.83	9.43
Free Cash Flow Margin	191.01%	140.48%	-41.91%	604.84%	-69.15%	86.80%
Free Cash Flow Per Share	8.57	3.45	-0.52	3.57	-1.18	1.25
Cash Income Tax Paid	-	1.03	1.13	-0.09	1.2	2.17

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.